Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Unger Kevin, Director. Officer active across 2 companies, notably Orthopediatrics CORP. Cumulatively, 3 disclosures have been published. Activity tracked since 2 June 2021. The latest transaction was filed on 1 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
Kevin Unger is a Board Member at Orthopediatrics Corp. In this role, he contributes to the governance and strategy of the company. Kevin has significant experience in the medical sector, having held various leadership positions. His expertise in product development and regulation is a valuable asset for Orthopediatrics.